Revolutionizing Antibody and Protein R&D with Benchling Solutions

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Products-Benchling

Revolutionizing Antibody and Protein R&D with Benchling Solutions

The Evolution of Antibody R&D

The field of antibodies and proteins is witnessing a transformative era in the fight against critical illnesses like cancer and immune system disorders. Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates are paving the way for more effective treatments with enhanced safety profiles. Antibody research and development (R&D) teams are embracing diverse formats, integrating cutting-edge technologies such as Next-Generation Sequencing (NGS) and CRISPR, and automating key processes to drive the development of groundbreaking antibodies.

The Need for a Modern Digital Solution

Benchling has recognized the industry's demand for advanced digital solutions that can cater to the complexity of modern antibody R&D. These solutions must offer flexibility to adapt to rapid industry changes and provide traceability to empower R&D teams with comprehensive insights into their programs and candidates. By offering an innovative R&D platform, Benchling enables scientists to design and develop next-generation biologics, ensuring scalability and efficiency throughout the research and development process.

Antibody and Protein R&D Solutions

Benchling's Antibody and Protein Solutions have gained the trust of hundreds of biopharma innovators worldwide. By leveraging this solution, researchers can explore various antibody and protein discovery modalities such as phage display, hybridoma, and B-cell research. The software is meticulously designed to accelerate speed, collaboration, and insights in biologics R&D. With integrated tools spanning in silico molecular biology, Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and Lab Execution System (LES), Benchling provides a cohesive digital platform for advancing biologic research.

Facilitating Collaboration and Insights

Through Benchling's Antibody and Protein Solutions, R&D teams can streamline collaboration by adopting structured workflows, templates, sample transfers, and seamless data sharing capabilities. The platform connects critical phases of the antibody R&D journey, spanning target identification, hit selection, sequencing, plasmid design, protein production, and in vitro/in vivo analyses. Additionally, scientists benefit from enhanced insights and traceability across the entire research process, enabling them to manage sequences, samples, and results efficiently within a secure cloud environment.

Customer Experience and Support

Benchling provides dedicated expertise through its Customer Experience professionals who possess deep scientific knowledge and IT best practices. These experts support antibody customers across a diverse range of R&D functions, ensuring a seamless user experience. Furthermore, Benchling offers continuous oversight through pre-implementation solutions consulting, professional implementation services, and customer success management to maximize the platform's utility for research teams. Additionally, foundational implementation guides developed by the Customer Experience team aid in providing focused R&D support to users.

Empowering Biotechnology Innovators

Highlighted by testimonials from organizations like Xilio Therapeutics, Benchling's solutions have empowered over 200,000 scientists across Fortune 500 companies, startups, and academic institutions. By offering end-to-end research and drug discovery platforms, Benchling continues to drive breakthroughs in the biotechnology landscape. With a commitment to innovation and customer success, Benchling remains a trusted partner for advancing antibody and protein R&D.

Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDC

ElevateBio: Revolutionizing Cell and Gene Therapy Research with Benchling's Digital Solutions

Transforming Infrastructure for Optimal CGT Development Processes

Cell and gene therapies (CGTs) are paving the way for advanced disease treatments and personalized medicines, with several already gaining FDA approval. However, one major challenge faced by CGT companies is the inefficiencies in their infrastructure, hindering the development of life-saving therapeutics. ElevateBio recognized these bottlenecks and set out to revolutionize CGT development by leveraging a groundbreaking solution. Through Benchling's integrated technologies model, ElevateBio is empowering the acceleration of design, manufacturing, and development of various genetic medicines. This unique platform offers turnkey scale and biotechnological capabilities, enabling CGT processes and programs to reach their full potential.

Read article

Welcome to Knowledge Base!

KB at your finger tips

Products-Benchling